Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie

In the context of COVID-19, the French Society of Pharmacology and Therapeutics opened a question-and-answer website on 17 March 2020 to provide clear and reliable answers to patients’ questions about the treatment of their chronic pathologies, to inform the general public about the proper use of me...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574859/
https://www.ncbi.nlm.nih.gov/pubmed/33100495
http://dx.doi.org/10.1016/j.actpha.2020.08.008
_version_ 1783597707692081152
collection PubMed
description In the context of COVID-19, the French Society of Pharmacology and Therapeutics opened a question-and-answer website on 17 March 2020 to provide clear and reliable answers to patients’ questions about the treatment of their chronic pathologies, to inform the general public about the proper use of medicines and to fight against misinformation. On May 13, 152 questions and answers were published and updated on this website, which was visited more than 154,000 times in two months.
format Online
Article
Text
id pubmed-7574859
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-75748592020-10-21 Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie Actual Pharm Article In the context of COVID-19, the French Society of Pharmacology and Therapeutics opened a question-and-answer website on 17 March 2020 to provide clear and reliable answers to patients’ questions about the treatment of their chronic pathologies, to inform the general public about the proper use of medicines and to fight against misinformation. On May 13, 152 questions and answers were published and updated on this website, which was visited more than 154,000 times in two months. Elsevier Masson SAS. 2020-10 2020-10-20 /pmc/articles/PMC7574859/ /pubmed/33100495 http://dx.doi.org/10.1016/j.actpha.2020.08.008 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie
title Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie
title_full Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie
title_fullStr Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie
title_full_unstemmed Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie
title_short Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie
title_sort genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574859/
https://www.ncbi.nlm.nih.gov/pubmed/33100495
http://dx.doi.org/10.1016/j.actpha.2020.08.008
work_keys_str_mv AT genesedunsitedinformationsurlebonusagedumedicamentaucoursdelapandemie
AT genesedunsitedinformationsurlebonusagedumedicamentaucoursdelapandemie

Ejemplares similares